| Primary angioplasty for acute myocardial infarction. | |
| | |
MedLine Citation:
|
PMID: 9575607 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The use of thrombolytic therapy has been widely accepted for the treatment of acute myocardial infarction. Despite improving mortality, thrombolytic therapy may be contraindicated in many patients presenting with myocardial infarction and is associated with a small, yet significant risk of hemorrhagic sequelae. This article outlines the rationale behind reperfusion therapy, the use of pharmacological thrombolysis and the role of adjunctive angioplasty. The potential advantages of a therapeutic strategy of primary angioplasty, instead of thrombolysis, are discussed. These include anatomical definition, risk stratification, reduced recurrent ischemia, enhanced coronary perfusion and improved coronary patency. The randomized trials in which primary angioplasty and thrombolytic therapy were compared are reviewed. We conclude that angioplasty results in a reduction of short-term mortality and nonfatal reinfarction and therefore advocate the routine use of coronary angioplasty as a primary reperfusion strategy for acute myocardial infarction. The potential limitations of primary angioplasty in the community hospital setting are discussed. Finally, we examine the roles of adjunctive mechanical (e.g. stents) and pharmacological (e.g. Abciximab) means of further enhancing outcomes after primary angioplasty. |
| | |
Authors:
|
C P Juergens; R J Whitbourn; A C Yeung; S N Oesterle |
Related Documents
:
|
7782397 - Angioplasty in acute myocardial infarction. 16645417 - Emergency repair of coronary perforation following percutaneous transluminal coronary a... 2945937 - Combined femorotibial bypass and distal intraoperative transluminal angioplasty. 2945677 - Early results of emergency surgery after coronary angioplasty. 22322367 - Three potential mechanisms for failure of hifu ablation in cardiac tissue. 10652967 - Progression from hypertension to heart failure. mechanisms and management. |
Publication Detail:
|
Type: Historical Article; Journal Article; Review |
Journal Detail:
|
Title: Vascular medicine (London, England) Volume: 2 ISSN: 1358-863X ISO Abbreviation: Vasc Med Publication Date: 1997 Nov |
Date Detail:
|
Created Date: 1998-06-16 Completed Date: 1998-06-16 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9610930 Medline TA: Vasc Med Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 327-34 Citation Subset: IM; Q |
Affiliation:
|
Division of Cardiovascular Medicine, Stanford University Medical Center, CA 94305, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Transluminal, Percutaneous Coronary*
/
history Combined Modality Therapy History, 20th Century Humans Intra-Aortic Balloon Pumping Myocardial Infarction / drug therapy, therapy* Myocardial Reperfusion Randomized Controlled Trials as Topic Stents Thrombolytic Therapy* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Lymphedema: anatomy, physiology and pathogenesis.
Next Document: Oxidative modification of cytochrome P450 and other macromolecules during its turnover